Nationwide Peptides GLP-1R 60 mg peptide vial
GLP-3R Peptide
$72.00 $425.00Price range: $72.00 through $425.00 Select options

GLP-3R Peptide

Price range: $72.00 through $425.00

GLP-3R is a synthetic 39-amino-acid triple-agonist peptide targeting GLP-1R, GIPR, and GCGR receptors, designed for controlled laboratory investigations of receptor activation pathways, energy balance signaling, glucose homeostasis, and lipid metabolism research models. For Research Use Only. Not for human use.

View Test Report

For Research Use Only — Not for Human Consumption
 

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

GLP-3R is an investigational triple-hormone receptor agonist that simultaneously activates glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). This triagonist profile is the subject of ongoing preclinical and clinical research examining synergistic receptor crosstalk effects not observed with single- or dual-agonist compounds. This research-grade lyophilized powder is synthesized under strict quality controls and accompanied by full analytical documentation. For Research Use Only. Not for human use.

Key Scientific Specifications

  • High-purity GLP-3R (≥98% by HPLC/MS, acetate salt form)
  • Verified 39-amino-acid sequence with lipidation and proprietary modifications for extended half-life
  • Lyophilized formulation for maximum long-term stability
  • Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and receptor-binding data
  • Manufactured in GMP-aligned, ISO-compliant facilities
  • Suitable for triple-agonist, energy balance, and hepatic lipid metabolism research models

Research-Referenced Attributes (Based on published preclinical and clinical literature; not therapeutic claims. For laboratory research use only.)

  • Triple receptor agonism (GLP-1R + GIPR + GCGR) — synergistic receptor activation studied in preclinical models
  • Phase 2 clinical trial data examining body weight as a primary endpoint at 48 weeks (pubmed.ncbi.nlm.nih.gov)
  • Preclinical and observational data examining glycemic markers and hepatic lipid content in research models (pmc.ncbi.nlm.nih.gov)
  • Glucagon receptor activation pathways studied in relation to energy expenditure and lipid oxidation in animal models
  • Triglyceride and cardiometabolic marker data examined in controlled research settings
  • Applicable across metabolic dysfunction, hepatic steatosis, glycemic regulation, and cardiovascular outcome research models

Why Researchers Choose GLP-3R from Nationwide Peptides

  • Sequence verified against published literature (including lipidation profile)
  • High purity with receptor-binding fidelity confirmed by COA
  • Transparent analytical data (HPLC ≥98%, triple-receptor activity confirmed)
  • Suitable for academic, pharmaceutical, and metabolic-disease laboratory research
  • Competitive research pricing with bulk options

This product is for laboratory research use only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease or condition.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.